<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>News Article and Medical Journal &#187; vaccine monitoring strategy</title>
	<atom:link href="http://d02now.com/tag/vaccine-monitoring-strategy/feed/" rel="self" type="application/rss+xml" />
	<link>http://d02now.com</link>
	<description></description>
	<lastBuildDate>Tue, 07 Dec 2010 17:40:30 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>Influenza A (H1N1) Vaccine Risk-Benefit Monitoring in Europe</title>
		<link>http://d02now.com/internal/animal-born-disease/swine-flu/influenza-a-h1n1-vaccine-risk-benefit-monitoring-in-europe.html</link>
		<comments>http://d02now.com/internal/animal-born-disease/swine-flu/influenza-a-h1n1-vaccine-risk-benefit-monitoring-in-europe.html#comments</comments>
		<pubDate>Mon, 30 Nov 2009 02:30:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Swine Flu]]></category>
		<category><![CDATA[Vaccine]]></category>
		<category><![CDATA[H1N1 Vaccine Europe]]></category>
		<category><![CDATA[vaccine monitoring strategy]]></category>

		<guid isPermaLink="false">http://d02now.com/internal/animal-born-disease/swine-flu/influenza-a-h1n1-vaccine-risk-benefit-monitoring-in-europe.html</guid>
		<description><![CDATA[The document covers materials such as Influenza A (H1N1) vaccines safety and effectiveness, the immunogenicity, benefit-risk evaluation, vaccine manufacturers, the vaccines authorised, research, clinical and public health centres, components of strategies in monitoring the benefit-risk  A/H1N1 vaccines, and the funding mechanisms in relation to the overall benefit-risk assesment.]]></description>
		<wfw:commentRss>http://d02now.com/internal/animal-born-disease/swine-flu/influenza-a-h1n1-vaccine-risk-benefit-monitoring-in-europe.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

